The potential for human safety and the therapeutic efficacy of NIR‐PIT targeting the epidermal growth factor receptor (EGFR) has been reported in patients with head and neck squamous cell carcinoma.23, 24. Here, EGFR is linked to head and neck squamous cell carcinoma.